Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory Securities Investigation

UTI EBITDA Guidance Cut Investigation

Analysis based on 7 articles · First reported Aug 10, 2026 · Last updated Aug 17, 2026

Sentiment
-60
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The guidance cut and subsequent investigation have negatively impacted UTI's stock price, reflecting investor concerns about the company's profitability and disclosure practices. The investigation could lead to legal costs and potential settlements, further affecting UTI's financial position and market sentiment.

Education Legal Services

Universal Technical Institute (UTI) lowered its fiscal 2026 baseline adjusted EBITDA outlook to above $135 million from more than $155 million, a reduction of roughly $20 million, citing weaker-than-expected fourth-quarter starts in the high-school auto and diesel channel and a faster mix shift toward shorter-duration, lower-margin programs. The company reported fiscal Q3 2026 revenue of $218.9 million, up 7.2% year over year, but shares fell sharply from $42.37 to $27.87, a decline of nearly 35%. Levi & Korsinsky, LLP launched an investigation into potential securities law violations, focusing on whether UTI adequately disclosed the risks to its outlook before the reduction. The investigation references statements made on the May 6, 2026 earnings call by CFO Bruce Schuman and CEO Jerome Grant, who reaffirmed the outlook and expressed confidence in student starts. The firm is seeking investors who suffered losses to participate in the investigation.

100 Universal Technical Institute lowered EBITDA guidance
90 Universal Technical Institute sold off shares
60 Universal Technical Institute reported revenue growth
stock
UTI is the subject of the investigation and the company that lowered its EBITDA guidance, causing a sharp stock decline. The company faces potential legal liabilities and reputational damage.
Importance 100.0 Sentiment -70.0
priv
Levi & Korsinsky is the law firm conducting the investigation, which could lead to securities litigation. The firm may benefit from contingency fees if a case is successful.
Importance 80.0 Sentiment 20.0
per
Bruce Schuman, CFO of UTI, reaffirmed the fiscal 2026 outlook on the May 6 earnings call. His statements are part of the investigation into potentially misleading disclosures.
Importance 50.0 Sentiment -30.0
per
Jerome Grant, CEO of UTI, expressed confidence in student starts on the May 6 call. His statements are also under scrutiny in the investigation.
Importance 50.0 Sentiment -30.0
per
Joseph E. Levi is a partner at Levi & Korsinsky and a contact for investors. His role is to solicit participation in the investigation.
Importance 40.0 Sentiment 10.0
exch
UTI is listed on the NYSE, where its shares traded and declined. The exchange itself is not directly affected by the event.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.